 TORONTO , Nov. 4, 2019 PRNewswire - Khiron Life Sciences Corp. Khiron or the Company TSXV: KHRN , OTCQB: KHRNF , Frankfurt : A2JMZC, a vertically integrated cannabis leader with core operations in Latin America , announces that Mark Monaghan has resigned as a director of the Company and that Deborah Rosati FCPA, FCA, ICD.D has been appointed effective immediately to the Board of Directors of the Company. Ms. Rosati has over 30 years of experience in leading and managing high growth companies and joins the Board, effective immediately. Deborah Rosati is an accomplished corporate director, entrepreneur and FCPA with more than 30 years of experience, including in consumer, cannabis, private equity and venture capital, and has advised over 20 private companies on business strategy and financial growth. Deborah is a past Board member and Chair of the Audit Committee at MedReleaf Corp. acquired by Aurora Cannabis, the Founder and CEO of Women Get On Board, a member-based company that connects, promotes and empowers women to corporate boards, and is the recipient of multiple finance and leadership awards. 